AI and Cancer Research ── Lung ── 2026-11-16
Lung cancer: treatment, trials and AI
- Abstract
Radiomics combined with clinical and dosimetric data may improve outcome prediction after lung stereotactic body radiotherapy (SBRT). This study aimed to develop machine-learning models to predict overall survival (OS) after lung SBRT for primary and metastatic lung tumours using planning-CT-derived features. Clinical and dosimetric data were retrospectively collected from six centres. Radiomic features were extracted using double tumour segmentation and filtered for reproducibility (intraclass correlation ≥ 0.80). From 181 lesions in 158 patients, 180 features (124 radiomic, 45 clinical, 11 dosimetric) were aggregated to the patient level. OS was modelled as a time-to-event outcome using random survival forests, per tumour origin and pooled with tumour origin as a covariate; features were selected by LASSO within cross-validation folds and interpreted with SHAP. The pooled model achieved a concordance index of 0.62 (95% CI 0.54–0.71) with time-dependent AUC of 0.69, 0.62 and 0.52 at 1, 2 and 3 years; a temporal split preserved this (0.61) whereas leave-one-centre-out validation gave a pooled concordance index of 0.57 (95% CI 0.48–0.65). Adding dosimetric and radiomic features to a clinical model increased discrimination (ΔC + 0.12, 95% CI 0.001–0.244). Recurrence- and metastasis-free survival, examined as secondary endpoints, were near chance. These leakage-free, censoring-appropriate models provide an honest, hypothesis-generating benchmark for OS prediction after lung SBRT, most informative at one year, that will require external validation.
Journal IF-equivalent: 5.9 (OpenAlex 2-year mean citedness, value as of 2026-11-04, retrieved 2026-11-05; not the official Clarivate IF)Reference: Invernizzi C, Benveniste PL, El Ayachy R, Leroy T, Blanchard N, Schipman B, et al. Machine learning-based prediction of overall survival after lung SBRT using clinical, dosimetric, and radiomics features: a multicenter study. Sci Rep. 2026 Nov 13 [Epub ahead of print]. doi:10.1038/s41598-026-77575-6.Checked: Abstract only - Abstract
Background: Current guidelines recommend upfront surgery without biopsy for patients with strongly suspected early-stage lung cancer, but this approach may be inappropriate for small cell lung cancer (SCLC). A noninvasive method for preoperatively distinguishing peripheral SCLC (p-SCLC) from peripheral non-small cell lung cancer (p-NSCLC) is crucial.
Methods: This multicenter study included 510 patients with peripheral solid lung nodules ≤ 3 cm, allocated to training set (n = 327), internal test set (n = 141), and prospective external test set (n = 42). After tumor segmentation on pretreatment computed tomography (CT) images, 1,223 radiomic features were extracted. Features were selected using the least absolute shrinkage and selection operator (LASSO) and maximum relevance minimum redundancy (mRMR) algorithms. Based on the filtered features, eight machine learning classifiers were trained on the training set to construct radiomics models. The best-performing radiomics model was subsequently combined with clinical variables to build a hybrid clinical-radiomics model. Performance was assessed using the area under the receiver operating characteristic curve (AUC), calibration analysis, and decision curve analysis (DCA).
Results: The Logistic Regression-based radiomics model showed the highest discrimination, with AUCs of 0.950 (95% confidence interval [CI] 0.916–0.977), 0.938 (0.888–0.978), and 0.919 (0.763–1.000) in the training, internal test, and external test sets, respectively. The hybrid model provided significantly better discrimination, with corresponding AUCs of 0.976 (0.953–0.992), 0.976 (0.949–0.995), and 0.983 (0.944–1.000). Calibration curves and DCA indicated better calibration and greater clinical net benefit for the hybrid model. The hybrid model also maintained good discrimination in subgroup analyses of patients with nodules ≤ 2 cm and patients with negative lymph nodes.
Conclusion: The hybrid clinical-radiomics model noninvasively distinguished p-SCLC from p-NSCLC with high accuracy and may support individualized preoperative evaluation and treatment planning.
Journal IF-equivalent: 4.5 (OpenAlex 2-year mean citedness, value as of 2026-11-13, retrieved 2026-11-15; not the official Clarivate IF)Reference: Liao S, Cao X, Lv D, Qi Q, Zhu K, Yao Y, et al. Machine learning models based on clinical-radiomics features to identify SCLC in ≤ 3 cm peripheral solid lung nodules: a multicenter study. Eur J Med Res. 2026 Nov 12 [Epub ahead of print]. doi:10.1186/s40001-026-05428-z.Checked: Abstract only